Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V P Miller

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Ethnohistory (Columbus, Ohio)|January 1, 1976
Aboriginal Micmac population: a review of the evidenceV P Miller
Healthplan|August 5, 1997
Managed care and the tobacco warsV P Miller
Hospitals|December 16, 1977
VA hospitals achieve 'zero energy growth'J D Chase, V P Miller
Pharmacology & Therapeutics|December 22, 1999
The use of heterologously expressed drug metabolizing enzymes--state of the art and prospects for the futureC L Crespi, V P Miller
Pharmacogenetics|June 1, 1997
The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductaseC L Crespi, V P Miller
Social Science & Medicine (1982)|March 17, 1999
Smoking-attributable medical care costs in the USAV P Miller, C Ernst, F Collin
The Journal of Biological Chemistry|May 15, 1990
Mechanistic studies of the biosynthesis of 3,6-dideoxyhexoses in Yersinia pseudotuberculosis. Purification and characterization of CDP-6-deoxy-delta 3,4-glucoseen reductase based on its NADH:dichlorophenolindolphenol oxidoreductase activityO Han, V P Miller, H W Liu
Science (New York, N.Y.)|January 12, 1979
OSHA carcinogen regulationsE S Allen, D Lindsay, V P Miller
Analytical Biochemistry|May 15, 1997
Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450C L Crespi, V P Miller, B W Penman
Biochemistry|February 25, 1992
Mechanistic and stereochemical studies of a unique dehydration catalyzed by CDP-4-keto-6-deoxy-D-glucose-3-dehydrase: a pyridoxamine 5'-phosphate dependent enzyme isolated from Yersinia pseudotuberculosisT M Weigel, V P Miller, H W Liu
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Ethnohistory (Columbus, Ohio)|January 1, 1976
Aboriginal Micmac population: a review of the evidenceV P Miller
Healthplan|August 5, 1997
Managed care and the tobacco warsV P Miller
Hospitals|December 16, 1977
VA hospitals achieve 'zero energy growth'J D Chase, V P Miller
Pharmacology & Therapeutics|December 22, 1999
The use of heterologously expressed drug metabolizing enzymes--state of the art and prospects for the futureC L Crespi, V P Miller
Pharmacogenetics|June 1, 1997
The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductaseC L Crespi, V P Miller
Social Science & Medicine (1982)|March 17, 1999
Smoking-attributable medical care costs in the USAV P Miller, C Ernst, F Collin
The Journal of Biological Chemistry|May 15, 1990
Mechanistic studies of the biosynthesis of 3,6-dideoxyhexoses in Yersinia pseudotuberculosis. Purification and characterization of CDP-6-deoxy-delta 3,4-glucoseen reductase based on its NADH:dichlorophenolindolphenol oxidoreductase activityO Han, V P Miller, H W Liu
Science (New York, N.Y.)|January 12, 1979
OSHA carcinogen regulationsE S Allen, D Lindsay, V P Miller
Analytical Biochemistry|May 15, 1997
Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450C L Crespi, V P Miller, B W Penman
Biochemistry|February 25, 1992
Mechanistic and stereochemical studies of a unique dehydration catalyzed by CDP-4-keto-6-deoxy-D-glucose-3-dehydrase: a pyridoxamine 5'-phosphate dependent enzyme isolated from Yersinia pseudotuberculosisT M Weigel, V P Miller, H W Liu
Pageof 3